Send to

Choose Destination
Indian J Dermatol Venereol Leprol. 2009 May-Jun;75(3):245-53; quiz 254. doi: 10.4103/0378-6323.51240.

Vaccines for human papillomavirus infection: a critical analysis.

Author information

Department of Dermatology, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry-605 006, India.


This article takes a critical look at the pros and cons of human papillomavirus (HPV) vaccines. There is enough evidence to suggest that the prophylactic vaccines are efficacious in preventing various benign and malignant conditions (including cervical cancers) caused by HPV. Even though the vaccine is costly, hypothetical analysis has shown that HPV vaccination will be cost effective in the long run. Therapeutic HPV vaccines used to treat established disease are still undergoing evaluation in clinical studies, and results seem to be encouraging. Although several countries have started mandatory vaccination programs with the prophylactic HPV vaccines, conservatives have voiced concerns regarding the moral impact of such vaccination programs.

[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd
Loading ...
Support Center